General Information of DTT (ID: TT6RIOV)

DTT Name Acyl-CoA desaturase (SCD) DTT Info
Gene Name SCD

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
1 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isoxyl DMJL10P Bacterial infection 1A00-1C4Z Approved [1]
------------------------------------------------------------------------------------
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Aramchol DMDLGRO Lipid metabolism disorder 5C52.Z Phase 2/3 [2]
MK-8245 DMG6KXB Type-2 diabetes 5A11 Phase 2 [3]
------------------------------------------------------------------------------------
5 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2-(4-benzoylpiperazin-1-yl)thiazole-5-carboxamide DMJA5Y4 Discovery agent N.A. Investigative [4]
CVT-12012 DMOCKMZ Diabetic complication 5A2Y Investigative [5]
ISIS 147919 DMTE3FJ Discovery agent N.A. Investigative [6]
MF-152 DMBLUSA Discovery agent N.A. Investigative [7]
Sterculic acid DM1PMR3 Discovery agent N.A. Investigative [8]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Has nature already identified all useful antibacterial targets Curr Opin Microbiol. 2008 Oct;11(5):387-92.
2 The fatty acid-bile acid conjugate Aramchol reduces liver fat content in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014 Dec;12(12):2085-91.e1.
3 Development of a liver-targeted stearoyl-CoA desaturase (SCD) inhibitor (MK-8245) to establish a therapeutic window for the treatment of diabetes and dyslipidemia. J Med Chem. 2011 Jul 28;54(14):5082-96.
4 Thiazole analog as stearoyl-CoA desaturase 1 inhibitor. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5214-7.
5 Potent, orally bioavailable, liver-selective stearoyl-CoA desaturase (SCD) inhibitors. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4070-4.
6 US patent application no. 7,132,529, Antisense modulation of stearoyl-CoA desaturase expression.
7 SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1593-7.
8 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015